Fexostad 180

Fexofenadine is a second generation antihistamine with specific and selective antagonistic effects on peripheral histamine H1 receptors. Fexofenadine is the active metabolite of terfenadine but no cardiotoxic because it does not inhibit the potassium channel involved in myocardial repolarization. At therapeutic doses, fexofenadine does not cause drowsiness or affect the central nervous system. The drug has a quick and long-lasting effect.

Pack size Box of 10 tablets
Shelf-life 24 months
Composition Fexofenadine hydrochloride
Dosage forms and strengths Film-coated tablet: 180 mg
Product code :



  • Relief of symptoms associated with seasonal allergic rhinitis in adults and children 12 years of age and older.
  • Treatment of uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 12 years of age and older.


  • Adults and children aged 12 years and over: The recommended dose of fexofenadine hydrochloride for children aged 12 years and over is 180 mg once daily taken before a meal.
  • Special populations: Studies in special risk groups (elderly, renally or hepatically impaired patients) indicate that it is not necessary to adjust the dose of fexofenadine hydrochloride in these patients.


Orally administered before a meal. Do not take fexofenadine with fruit juices as orange, grapefruit or apple juice.

Patients with known hypersensitivity to fexofenadine hydrochloride or to any of the ingredients.


  • Drowsiness, fatigue, headache, insomnia, dizziness.
  • Nausea, indigestion.
  • Susceptible to virus infection (cold, flu), dysmenorrhea, upper respiratory tract infections, itchy throat, cough, fever, otitis media, sinusitis, back pain.
  • Caution and an appropriate dose adjustment should be made to patients with impaired renal function because plasma concentrations are increased due to a prolonged half-life.
  • Cautions should be taken when using the drug in the elderly (over 65 years of age) who often have physiological decline in renal function.
  • The efficacy and safety of fexofenadine hydrochloride 180 mg has not been studied in children under 12.
  • Do not arbitrarily add another H1 antihistamine while using fexofenadine.
  • Fexofenadine should be discontinued at least 24 – 48 hours prior to intradermal injection antigen tests.
  • Taking fexofenadine causes exacerbation of psoriasis.
  • Fexofenadine hydrochloride should not be used during pregnancy unless clearly necessary.
  • There are no data on the content of human milk after administering fexofenadine hydrochloride. Therefore fexofenadine hydrochloride is not recommended for mothers breastfeeding their babies.
  • Although fexofenadine is less likely to cause drowsiness, caution should be exercised when driving or operating machinery that requires alertness.